Klebsiellen-Leberabszess

 

 Buy Article Permissions and Reprints

Zusammenfassung

Klebsiellen-Leberabszesse (KLA) sind als abgegrenzte Eiteransammlung im Lebergewebe aufgrund einer Infektion mit gramnegativen Bakterien der Gattung Klebsiella definiert ([Abb. 1]). Als „emerging infections“ erlangen insbesondere hypervirulente Klebsiella pneumoniae (hvKP) der Kapsel-Serotypen 1 und 2 (K1, K2) weltweit eine zunehmende Bedeutung, da sie oft zu rezidivierenden Infektionen führen und schwer zu sanieren sind. Neben einer adäquaten Antibiotikatherapie bis zur vollständigen Abszessresolution müssen größere Abszesse invasiv behandelt werden. Das Auftreten multiresistenter hypervirulenter Klebsiellen-Stämme bereitet aufgrund der limitierten Therapieoptionen zunehmend Sorgen.

Publication History

Article published online:
11 November 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Zhu J, Wang T, Chen L. et al. Virulence Factors in Hypervirulent Klebsiella pneumoniae. Front Microbiol 2021; 12: 642484 DOI: 10.3389/fmicb.2021.642484. (PMID: 33897652)
  CrossrefPubMedGoogle Scholar
• 2 Lippmann N, Lübbert C, Kaiser T. et al. Clinical epidemiology of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2014; 14: 271-272 DOI: 10.1016/S1473-3099(14)70705-4. (PMID: 24670625)
  CrossrefPubMedGoogle Scholar
• 3 Viehweger A, Blumenscheit C, Lippmann N. et al. Context-aware genomic surveillance reveals hidden transmission of a carbapenemase-producing Klebsiella pneumoniae. Microb Genom 2021; 7 DOI: 10.1099/mgen.0.000741. (PMID: 34913861)
  CrossrefPubMedGoogle Scholar
• 4 Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 1986; 146: 1913-1916 (PMID: 3532983)
  CrossrefPubMedGoogle Scholar
• 5 Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev 2019; 32 (03) e00001-e00019 DOI: 10.1128/CMR.00001-19. (PMID: 31092506)
  CrossrefPubMedGoogle Scholar
• 6 Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae – clinical and molecular perspectives. J Intern Med 2020; 287: 283-300 DOI: 10.1111/joim.13007. (PMID: 31677303)
  CrossrefPubMedGoogle Scholar
• 7 Wang TC, Lin JC, Chang JC. et al. Virulence among different types of hypervirulent Klebsiella pneumoniae with multi-locus sequence type (MLST)-11, Serotype K1 or K2 strains. Gut Pathog 2021; 13: 40 DOI: 10.1186/s13099-021-00439-z. (PMID: 34154656)
  CrossrefPubMedGoogle Scholar
• 8 Wendt S, Lübbert C, Karlas T. An Emerging Cause for Liver Abscesses With Poor Prognosis. Gastroenterology 2018; 155: e18-e19 DOI: 10.1053/j.gastro.2017.12.032. (PMID: 29409829)
  CrossrefPubMedGoogle Scholar
• 9 Pichler C, Büchsel M, Rossen JW. et al. First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016. New Microbes New Infect 2017; 17: 77-80 DOI: 10.1016/j.nmni.2017.02.006. (PMID: 28392922)
  CrossrefPubMedGoogle Scholar
• 10 Gu D, Dong N, Zheng Z. et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2018; 18: 37-46 DOI: 10.1016/S1473-3099(17)30489-9. (PMID: 28864030)
  CrossrefPubMedGoogle Scholar
• 11 Zimmermann L, Wendt S, Lübbert C. et al. Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance. United European Gastroenterol J 2021; 9: 1039-1047 DOI: 10.1002/ueg2.12132. (PMID: 34329537)
  CrossrefPubMedGoogle Scholar
• 12 Siu LK, Yeh KM, Lin JC. et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infectious Diseases 2012; 12: 881-887 DOI: 10.1016/S1473-3099(12)70205-0. (PMID: 35487634)
  CrossrefPubMedGoogle Scholar
• 13 Luo M, Yang XX, Tan B. et al. Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis. Eur J Clin Microbiol Infect Dis 2016; 35: 1557-1565 DOI: 10.1007/s10096-016-2712-y.
  CrossrefPubMedGoogle Scholar
• 14 Mücke MM, Kessel J, Mücke VT. et al. The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses. BMC Infect Dis 2017; 17: 450 DOI: 10.1186/s12879-017-2543-1. (PMID: 28651522)
  CrossrefPubMedGoogle Scholar
• 15 Bruns T, Stallmach A. Bakterielle hepatobiliäre Infektionen : Erregerspektrum, antimikrobielle Resistenzentwicklung und aktuelle Therapiekonzepte. Internist (Berl) 2022; 63: 349-366 DOI: 10.1007/s00108-022-01277-0. (PMID: 35238985)
  CrossrefPubMedGoogle Scholar
• 16 Große K, Ohm D, Würstle S. et al. Clinical characteristics and outcome of patients with enterococcal liver abscess. Sci Rep 2021; 11: 22265 DOI: 10.1038/s41598-021-01620-9. (PMID: 34782684)
  CrossrefPubMedGoogle Scholar
• 17 Yin D, Ji C, Zhang S. et al. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective study. Liver Int 2021; 41: 810-818 DOI: 10.1111/liv.14760. (PMID: 33314531)
  CrossrefPubMedGoogle Scholar
• 18 Tian LT, Yao K, Zhang XY. et al. Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clin Microbiol Infect 2012; 18: E314-30 DOI: 10.1111/j.1469-0691.2012.03912.x. (PMID: 22676078)
  CrossrefPubMedGoogle Scholar
• 19 Kong H, Yu F, Zhang W. et al. Clinical and microbiological characteristics of pyogenic liver abscess in a tertiary hospital in East China. Medicine (Baltimore) 2017; 96: e8050 DOI: 10.1097/MD.0000000000008050. (PMID: 28906397)
  CrossrefPubMedGoogle Scholar
• 20 Chen CH, Wu SS, Chang HC. et al. Initial presentations and final outcomes of primary pyogenic liver abscess: a cross-sectional study. BMC Gastroenterol 2014; 14: 133 DOI: 10.1186/1471-230X-14-133. (PMID: 25066384)
  CrossrefPubMedGoogle Scholar
• 21 Zhang S, Zhang X, Wu Q. et al. Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob Resist Infect Control 2019; 8: 166 DOI: 10.1186/s13756-019-0615-2. (PMID: 31673355)
  CrossrefPubMedGoogle Scholar
• 22 Rahimian J, Wilson T, Oram V. et al. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 2004; 39: 1654-1659 DOI: 10.1086/425616. (PMID: 15578367)
  CrossrefPubMedGoogle Scholar
• 23 Pang TCY, Fung T, Samra J. et al. Pyogenic liver abscess: an audit of 10 years' experience. World J Gastroenterol 2011; 17: 1622-1630 DOI: 10.3748/wjg.v17.i12.1622. (PMID: 21472130)
  CrossrefPubMedGoogle Scholar
• 24 Lübbert C, Wiegand J, Karlas T. Therapy of Liver Abscesses. Viszeralmedizin 2014; 30: 334-341 DOI: 10.1159/000366579. (PMID: 26287275)
  CrossrefPubMedGoogle Scholar
• 25 Zou Q, Li Y. Hypervirulent Klebsiella pneumoniae. N Engl J Med 2021; 385: 833 DOI: 10.1056/NEJMicm2101602. (PMID: 34415687)
  CrossrefPubMedGoogle Scholar
• 26 Kunze G, Staritz M, Köhler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess. Ultrasound Med Biol 2015; 41: 952-959 DOI: 10.1016/j.ultrasmedbio.2014.12.001. (PMID: 25701525)
  CrossrefPubMedGoogle Scholar
• 27 Bielow T, Blank V, Opitz S. et al. Klebsiella Pneumoniae Liver Abscess Syndrome – A Challenge for Contrast-Enhanced Ultrasound. Ultrasound Int Open 2021; 7: E2-E5 DOI: 10.1055/a-1471-6907. (PMID: 33889805)
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Eisenmenger EF, Guajardo E, Finch N. et al. ‘String Test’ for Hypermucoviscous Klebsiella pneumoniae. Am J Med 2021; 134: e520-e521 DOI: 10.1016/j.amjmed.2021.03.047. (PMID: 34010600)
  CrossrefPubMedGoogle Scholar
• 29 Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes?. Virulence 2017; 8: 1111-1123 DOI: 10.1080/21505594.2017.1317412. (PMID: 28402698)
  CrossrefPubMedGoogle Scholar
• 30 Gomi H, Solomkin JS, Schlossberg D. et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25: 3-16 DOI: 10.1002/jhbp.518. (PMID: 29090866)
  CrossrefPubMedGoogle Scholar
• 31 Molton JS, Chan M, Kalimuddin S. et al. Oral vs Intravenous Antibiotics for Patients With Klebsiella pneumoniae Liver Abscess: A Randomized, Controlled Noninferiority Study. Clin Infect Dis 2020; 71: 952-959 DOI: 10.1093/cid/ciz881. (PMID: 31641767)
  CrossrefPubMedGoogle Scholar
• 32 Singh S, Chaudhary P, Saxena N. et al. Treatment of liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Ann Gastroenterol 2013; 26: 332-339 (PMID: 24714320)
  PubMedGoogle Scholar
• 33 Rajak CL, Gupta S, Jain S. et al. Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. AJR Am J Roentgenol 1998; 170: 1035-1039 DOI: 10.2214/ajr.170.4.9530055.. (PMID: 9530055)
  CrossrefPubMedGoogle Scholar
• 34 Yu SCH, Ho SSM, Lau WY. et al. Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Hepatology 2004; 39: 932-938 DOI: 10.1002/hep.20133. (PMID: 15057896)
  CrossrefPubMedGoogle Scholar
• 35 Czerwonko ME, Huespe P, Bertone S. et al. Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. HPB (Oxford) 2016; 18: 1023-1030 DOI: 10.1016/j.hpb.2016.09.001. (PMID: 27712972)
  CrossrefPubMedGoogle Scholar